Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity
Spasticity is a persistent and debilitating consequence of stroke and effective rehabilitation is a healthcare priority. Botulinum neurotoxin A (BoNT-A) with supportive therapy has increasingly been embedded within clinical practice for treatment of post-stroke spasticity. But the evidence for this...
Saved in:
Main Authors: | Rachel Milte, Jia Song, Sean Docking, Julie Ratcliffe, Ian D. Cameron, Maria Crotty, Louise Ada, Coralie English, Natasha A. Lannin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/17/7/341 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum Neurotoxin A-Induced Muscle Morphology Changes in Children with Cerebral Palsy: A One-Year Follow-Up Study
by: Charlotte Lambrechts, et al.
Published: (2025-06-01) -
The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review
by: Anton Rubis, et al.
Published: (2020-06-01) -
Pathogenicity and virulence of Clostridium botulinum
by: Alexander M. Rawson, et al.
Published: (2023-12-01) -
Neurotropic Effect of Botulinum Toxin and the Potential of Specific Serum Therapy in Botulism (Review)
by: E. M. Eliseeva, et al.
Published: (2024-10-01) -
Hemimasticatory spasm. Own experience of using botulinum neuroprotein type A
by: A. N. Korenko, et al.
Published: (2022-04-01)